This federal contract award, valued at $12,558.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of XELJANZ XR 11 MG TABLET 30S, a specialty medication, with an ultimate completion date of November 20, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular contract award was not designated with a set-aside requirement, indicating open competition.
Generated 2/18/25, 1:43 PM